ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gene Knockdown Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-1I6429
Home | Market Reports | Computers & Electronics| Software
Global Gene Knockdown Market Insights Forecast to 2028
BUY CHAPTERS

Global Gene Knockdown Market Research Report 2025

Code: QYRE-Auto-1I6429
Report
January 2025
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Santa Cruz Biotechnology(US)
Origene(US)
Sigma-Aldrich(US)
Abnova (Taiwan)
Agilent Technologies(US)
Bio-Rad (US)
Cell Signaling Technology (US)
GeneCopoeia (US)
siTOOLs Biotech (Germany)
Novus Biologicals(US)
EMD Millipore (US)
BioVision(US)
Creative Biomart (US)
Selleck Chemicals (US)
MyBioSource (US)
Invitrogen(US)
Qiagen (Germany)

Gene Knockdown Market

The global market for Gene Knockdown was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Gene Knockdown is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Gene Knockdown is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Gene Knockdown in Medical is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Gene Knockdown include Santa Cruz Biotechnology (US), OriGene (US), Sigma-Aldrich (US), Abnova (Taiwan), Agilent Technologies (US), Bio-Rad (US), Cell Signaling Technology (US), GeneCopoeia (US), siTOOLs Biotech (Germany), Novus Biologicals (US), etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Gene Knockdown, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Knockdown.
The Gene Knockdown market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gene Knockdown market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Knockdown companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Gene Knockdown Market Report

Report Metric Details
Report Name Gene Knockdown Market
Segment by Type
Segment by Application
  • Medical
  • Bioengineering
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Santa Cruz Biotechnology (US), OriGene (US), Sigma-Aldrich (US), Abnova (Taiwan), Agilent Technologies (US), Bio-Rad (US), Cell Signaling Technology (US), GeneCopoeia (US), siTOOLs Biotech (Germany), Novus Biologicals (US), EMD Millipore (US), BioVision (US), Creative Biomart (US), Selleck Chemicals (US), MyBioSource (US), Invitrogen (US), Qiagen (Germany)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Gene Knockdown company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Gene Knockdown Market report?

Ans: The main players in the Gene Knockdown Market are Santa Cruz Biotechnology (US), OriGene (US), Sigma-Aldrich (US), Abnova (Taiwan), Agilent Technologies (US), Bio-Rad (US), Cell Signaling Technology (US), GeneCopoeia (US), siTOOLs Biotech (Germany), Novus Biologicals (US), EMD Millipore (US), BioVision (US), Creative Biomart (US), Selleck Chemicals (US), MyBioSource (US), Invitrogen (US), Qiagen (Germany)

What are the Application segmentation covered in the Gene Knockdown Market report?

Ans: The Applications covered in the Gene Knockdown Market report are Medical, Bioengineering, Other

What are the Type segmentation covered in the Gene Knockdown Market report?

Ans: The Types covered in the Gene Knockdown Market report are siRNA, shRNA, Other

Recommended Reports

Gene Therapy Markets

Gene Editing & Synthesis

Gene Analysis & Delivery

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Knockdown Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 siRNA
1.2.3 shRNA
1.2.4 Other
1.3 Market by Application
1.3.1 Global Gene Knockdown Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Medical
1.3.3 Bioengineering
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Knockdown Market Perspective (2020-2031)
2.2 Global Gene Knockdown Growth Trends by Region
2.2.1 Global Gene Knockdown Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Gene Knockdown Historic Market Size by Region (2020-2025)
2.2.3 Gene Knockdown Forecasted Market Size by Region (2026-2031)
2.3 Gene Knockdown Market Dynamics
2.3.1 Gene Knockdown Industry Trends
2.3.2 Gene Knockdown Market Drivers
2.3.3 Gene Knockdown Market Challenges
2.3.4 Gene Knockdown Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Knockdown Players by Revenue
3.1.1 Global Top Gene Knockdown Players by Revenue (2020-2025)
3.1.2 Global Gene Knockdown Revenue Market Share by Players (2020-2025)
3.2 Global Gene Knockdown Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Gene Knockdown Revenue
3.4 Global Gene Knockdown Market Concentration Ratio
3.4.1 Global Gene Knockdown Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Knockdown Revenue in 2024
3.5 Global Key Players of Gene Knockdown Head office and Area Served
3.6 Global Key Players of Gene Knockdown, Product and Application
3.7 Global Key Players of Gene Knockdown, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Knockdown Breakdown Data by Type
4.1 Global Gene Knockdown Historic Market Size by Type (2020-2025)
4.2 Global Gene Knockdown Forecasted Market Size by Type (2026-2031)
5 Gene Knockdown Breakdown Data by Application
5.1 Global Gene Knockdown Historic Market Size by Application (2020-2025)
5.2 Global Gene Knockdown Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Gene Knockdown Market Size (2020-2031)
6.2 North America Gene Knockdown Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Gene Knockdown Market Size by Country (2020-2025)
6.4 North America Gene Knockdown Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Knockdown Market Size (2020-2031)
7.2 Europe Gene Knockdown Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Gene Knockdown Market Size by Country (2020-2025)
7.4 Europe Gene Knockdown Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Knockdown Market Size (2020-2031)
8.2 Asia-Pacific Gene Knockdown Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Gene Knockdown Market Size by Region (2020-2025)
8.4 Asia-Pacific Gene Knockdown Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Knockdown Market Size (2020-2031)
9.2 Latin America Gene Knockdown Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Gene Knockdown Market Size by Country (2020-2025)
9.4 Latin America Gene Knockdown Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Knockdown Market Size (2020-2031)
10.2 Middle East & Africa Gene Knockdown Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Gene Knockdown Market Size by Country (2020-2025)
10.4 Middle East & Africa Gene Knockdown Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Santa Cruz Biotechnology (US)
11.1.1 Santa Cruz Biotechnology (US) Company Details
11.1.2 Santa Cruz Biotechnology (US) Business Overview
11.1.3 Santa Cruz Biotechnology (US) Gene Knockdown Introduction
11.1.4 Santa Cruz Biotechnology (US) Revenue in Gene Knockdown Business (2020-2025)
11.1.5 Santa Cruz Biotechnology (US) Recent Development
11.2 OriGene (US)
11.2.1 OriGene (US) Company Details
11.2.2 OriGene (US) Business Overview
11.2.3 OriGene (US) Gene Knockdown Introduction
11.2.4 OriGene (US) Revenue in Gene Knockdown Business (2020-2025)
11.2.5 OriGene (US) Recent Development
11.3 Sigma-Aldrich (US)
11.3.1 Sigma-Aldrich (US) Company Details
11.3.2 Sigma-Aldrich (US) Business Overview
11.3.3 Sigma-Aldrich (US) Gene Knockdown Introduction
11.3.4 Sigma-Aldrich (US) Revenue in Gene Knockdown Business (2020-2025)
11.3.5 Sigma-Aldrich (US) Recent Development
11.4 Abnova (Taiwan)
11.4.1 Abnova (Taiwan) Company Details
11.4.2 Abnova (Taiwan) Business Overview
11.4.3 Abnova (Taiwan) Gene Knockdown Introduction
11.4.4 Abnova (Taiwan) Revenue in Gene Knockdown Business (2020-2025)
11.4.5 Abnova (Taiwan) Recent Development
11.5 Agilent Technologies (US)
11.5.1 Agilent Technologies (US) Company Details
11.5.2 Agilent Technologies (US) Business Overview
11.5.3 Agilent Technologies (US) Gene Knockdown Introduction
11.5.4 Agilent Technologies (US) Revenue in Gene Knockdown Business (2020-2025)
11.5.5 Agilent Technologies (US) Recent Development
11.6 Bio-Rad (US)
11.6.1 Bio-Rad (US) Company Details
11.6.2 Bio-Rad (US) Business Overview
11.6.3 Bio-Rad (US) Gene Knockdown Introduction
11.6.4 Bio-Rad (US) Revenue in Gene Knockdown Business (2020-2025)
11.6.5 Bio-Rad (US) Recent Development
11.7 Cell Signaling Technology (US)
11.7.1 Cell Signaling Technology (US) Company Details
11.7.2 Cell Signaling Technology (US) Business Overview
11.7.3 Cell Signaling Technology (US) Gene Knockdown Introduction
11.7.4 Cell Signaling Technology (US) Revenue in Gene Knockdown Business (2020-2025)
11.7.5 Cell Signaling Technology (US) Recent Development
11.8 GeneCopoeia (US)
11.8.1 GeneCopoeia (US) Company Details
11.8.2 GeneCopoeia (US) Business Overview
11.8.3 GeneCopoeia (US) Gene Knockdown Introduction
11.8.4 GeneCopoeia (US) Revenue in Gene Knockdown Business (2020-2025)
11.8.5 GeneCopoeia (US) Recent Development
11.9 siTOOLs Biotech (Germany)
11.9.1 siTOOLs Biotech (Germany) Company Details
11.9.2 siTOOLs Biotech (Germany) Business Overview
11.9.3 siTOOLs Biotech (Germany) Gene Knockdown Introduction
11.9.4 siTOOLs Biotech (Germany) Revenue in Gene Knockdown Business (2020-2025)
11.9.5 siTOOLs Biotech (Germany) Recent Development
11.10 Novus Biologicals (US)
11.10.1 Novus Biologicals (US) Company Details
11.10.2 Novus Biologicals (US) Business Overview
11.10.3 Novus Biologicals (US) Gene Knockdown Introduction
11.10.4 Novus Biologicals (US) Revenue in Gene Knockdown Business (2020-2025)
11.10.5 Novus Biologicals (US) Recent Development
11.11 EMD Millipore (US)
11.11.1 EMD Millipore (US) Company Details
11.11.2 EMD Millipore (US) Business Overview
11.11.3 EMD Millipore (US) Gene Knockdown Introduction
11.11.4 EMD Millipore (US) Revenue in Gene Knockdown Business (2020-2025)
11.11.5 EMD Millipore (US) Recent Development
11.12 BioVision (US)
11.12.1 BioVision (US) Company Details
11.12.2 BioVision (US) Business Overview
11.12.3 BioVision (US) Gene Knockdown Introduction
11.12.4 BioVision (US) Revenue in Gene Knockdown Business (2020-2025)
11.12.5 BioVision (US) Recent Development
11.13 Creative Biomart (US)
11.13.1 Creative Biomart (US) Company Details
11.13.2 Creative Biomart (US) Business Overview
11.13.3 Creative Biomart (US) Gene Knockdown Introduction
11.13.4 Creative Biomart (US) Revenue in Gene Knockdown Business (2020-2025)
11.13.5 Creative Biomart (US) Recent Development
11.14 Selleck Chemicals (US)
11.14.1 Selleck Chemicals (US) Company Details
11.14.2 Selleck Chemicals (US) Business Overview
11.14.3 Selleck Chemicals (US) Gene Knockdown Introduction
11.14.4 Selleck Chemicals (US) Revenue in Gene Knockdown Business (2020-2025)
11.14.5 Selleck Chemicals (US) Recent Development
11.15 MyBioSource (US)
11.15.1 MyBioSource (US) Company Details
11.15.2 MyBioSource (US) Business Overview
11.15.3 MyBioSource (US) Gene Knockdown Introduction
11.15.4 MyBioSource (US) Revenue in Gene Knockdown Business (2020-2025)
11.15.5 MyBioSource (US) Recent Development
11.16 Invitrogen (US)
11.16.1 Invitrogen (US) Company Details
11.16.2 Invitrogen (US) Business Overview
11.16.3 Invitrogen (US) Gene Knockdown Introduction
11.16.4 Invitrogen (US) Revenue in Gene Knockdown Business (2020-2025)
11.16.5 Invitrogen (US) Recent Development
11.17 Qiagen (Germany)
11.17.1 Qiagen (Germany) Company Details
11.17.2 Qiagen (Germany) Business Overview
11.17.3 Qiagen (Germany) Gene Knockdown Introduction
11.17.4 Qiagen (Germany) Revenue in Gene Knockdown Business (2020-2025)
11.17.5 Qiagen (Germany) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Santa Cruz Biotechnology(US)
Origene(US)
Sigma-Aldrich(US)
Abnova (Taiwan)
Agilent Technologies(US)
Bio-Rad (US)
Cell Signaling Technology (US)
GeneCopoeia (US)
siTOOLs Biotech (Germany)
Novus Biologicals(US)
EMD Millipore (US)
BioVision(US)
Creative Biomart (US)
Selleck Chemicals (US)
MyBioSource (US)
Invitrogen(US)
Qiagen (Germany)
List of Tables
 Table 1. Global Gene Knockdown Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of siRNA
 Table 3. Key Players of shRNA
 Table 4. Key Players of Other
 Table 5. Global Gene Knockdown Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Gene Knockdown Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Gene Knockdown Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Gene Knockdown Market Share by Region (2020-2025)
 Table 9. Global Gene Knockdown Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Gene Knockdown Market Share by Region (2026-2031)
 Table 11. Gene Knockdown Market Trends
 Table 12. Gene Knockdown Market Drivers
 Table 13. Gene Knockdown Market Challenges
 Table 14. Gene Knockdown Market Restraints
 Table 15. Global Gene Knockdown Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Gene Knockdown Market Share by Players (2020-2025)
 Table 17. Global Top Gene Knockdown Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Knockdown as of 2024)
 Table 18. Ranking of Global Top Gene Knockdown Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Gene Knockdown Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Gene Knockdown, Headquarters and Area Served
 Table 21. Global Key Players of Gene Knockdown, Product and Application
 Table 22. Global Key Players of Gene Knockdown, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Gene Knockdown Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Gene Knockdown Revenue Market Share by Type (2020-2025)
 Table 26. Global Gene Knockdown Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Gene Knockdown Revenue Market Share by Type (2026-2031)
 Table 28. Global Gene Knockdown Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Gene Knockdown Revenue Market Share by Application (2020-2025)
 Table 30. Global Gene Knockdown Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Gene Knockdown Revenue Market Share by Application (2026-2031)
 Table 32. North America Gene Knockdown Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Gene Knockdown Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Gene Knockdown Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Gene Knockdown Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Gene Knockdown Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Gene Knockdown Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Gene Knockdown Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Gene Knockdown Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Gene Knockdown Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Gene Knockdown Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Gene Knockdown Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Gene Knockdown Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Gene Knockdown Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Gene Knockdown Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Gene Knockdown Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Santa Cruz Biotechnology (US) Company Details
 Table 48. Santa Cruz Biotechnology (US) Business Overview
 Table 49. Santa Cruz Biotechnology (US) Gene Knockdown Product
 Table 50. Santa Cruz Biotechnology (US) Revenue in Gene Knockdown Business (2020-2025) & (US$ Million)
 Table 51. Santa Cruz Biotechnology (US) Recent Development
 Table 52. OriGene (US) Company Details
 Table 53. OriGene (US) Business Overview
 Table 54. OriGene (US) Gene Knockdown Product
 Table 55. OriGene (US) Revenue in Gene Knockdown Business (2020-2025) & (US$ Million)
 Table 56. OriGene (US) Recent Development
 Table 57. Sigma-Aldrich (US) Company Details
 Table 58. Sigma-Aldrich (US) Business Overview
 Table 59. Sigma-Aldrich (US) Gene Knockdown Product
 Table 60. Sigma-Aldrich (US) Revenue in Gene Knockdown Business (2020-2025) & (US$ Million)
 Table 61. Sigma-Aldrich (US) Recent Development
 Table 62. Abnova (Taiwan) Company Details
 Table 63. Abnova (Taiwan) Business Overview
 Table 64. Abnova (Taiwan) Gene Knockdown Product
 Table 65. Abnova (Taiwan) Revenue in Gene Knockdown Business (2020-2025) & (US$ Million)
 Table 66. Abnova (Taiwan) Recent Development
 Table 67. Agilent Technologies (US) Company Details
 Table 68. Agilent Technologies (US) Business Overview
 Table 69. Agilent Technologies (US) Gene Knockdown Product
 Table 70. Agilent Technologies (US) Revenue in Gene Knockdown Business (2020-2025) & (US$ Million)
 Table 71. Agilent Technologies (US) Recent Development
 Table 72. Bio-Rad (US) Company Details
 Table 73. Bio-Rad (US) Business Overview
 Table 74. Bio-Rad (US) Gene Knockdown Product
 Table 75. Bio-Rad (US) Revenue in Gene Knockdown Business (2020-2025) & (US$ Million)
 Table 76. Bio-Rad (US) Recent Development
 Table 77. Cell Signaling Technology (US) Company Details
 Table 78. Cell Signaling Technology (US) Business Overview
 Table 79. Cell Signaling Technology (US) Gene Knockdown Product
 Table 80. Cell Signaling Technology (US) Revenue in Gene Knockdown Business (2020-2025) & (US$ Million)
 Table 81. Cell Signaling Technology (US) Recent Development
 Table 82. GeneCopoeia (US) Company Details
 Table 83. GeneCopoeia (US) Business Overview
 Table 84. GeneCopoeia (US) Gene Knockdown Product
 Table 85. GeneCopoeia (US) Revenue in Gene Knockdown Business (2020-2025) & (US$ Million)
 Table 86. GeneCopoeia (US) Recent Development
 Table 87. siTOOLs Biotech (Germany) Company Details
 Table 88. siTOOLs Biotech (Germany) Business Overview
 Table 89. siTOOLs Biotech (Germany) Gene Knockdown Product
 Table 90. siTOOLs Biotech (Germany) Revenue in Gene Knockdown Business (2020-2025) & (US$ Million)
 Table 91. siTOOLs Biotech (Germany) Recent Development
 Table 92. Novus Biologicals (US) Company Details
 Table 93. Novus Biologicals (US) Business Overview
 Table 94. Novus Biologicals (US) Gene Knockdown Product
 Table 95. Novus Biologicals (US) Revenue in Gene Knockdown Business (2020-2025) & (US$ Million)
 Table 96. Novus Biologicals (US) Recent Development
 Table 97. EMD Millipore (US) Company Details
 Table 98. EMD Millipore (US) Business Overview
 Table 99. EMD Millipore (US) Gene Knockdown Product
 Table 100. EMD Millipore (US) Revenue in Gene Knockdown Business (2020-2025) & (US$ Million)
 Table 101. EMD Millipore (US) Recent Development
 Table 102. BioVision (US) Company Details
 Table 103. BioVision (US) Business Overview
 Table 104. BioVision (US) Gene Knockdown Product
 Table 105. BioVision (US) Revenue in Gene Knockdown Business (2020-2025) & (US$ Million)
 Table 106. BioVision (US) Recent Development
 Table 107. Creative Biomart (US) Company Details
 Table 108. Creative Biomart (US) Business Overview
 Table 109. Creative Biomart (US) Gene Knockdown Product
 Table 110. Creative Biomart (US) Revenue in Gene Knockdown Business (2020-2025) & (US$ Million)
 Table 111. Creative Biomart (US) Recent Development
 Table 112. Selleck Chemicals (US) Company Details
 Table 113. Selleck Chemicals (US) Business Overview
 Table 114. Selleck Chemicals (US) Gene Knockdown Product
 Table 115. Selleck Chemicals (US) Revenue in Gene Knockdown Business (2020-2025) & (US$ Million)
 Table 116. Selleck Chemicals (US) Recent Development
 Table 117. MyBioSource (US) Company Details
 Table 118. MyBioSource (US) Business Overview
 Table 119. MyBioSource (US) Gene Knockdown Product
 Table 120. MyBioSource (US) Revenue in Gene Knockdown Business (2020-2025) & (US$ Million)
 Table 121. MyBioSource (US) Recent Development
 Table 122. Invitrogen (US) Company Details
 Table 123. Invitrogen (US) Business Overview
 Table 124. Invitrogen (US) Gene Knockdown Product
 Table 125. Invitrogen (US) Revenue in Gene Knockdown Business (2020-2025) & (US$ Million)
 Table 126. Invitrogen (US) Recent Development
 Table 127. Qiagen (Germany) Company Details
 Table 128. Qiagen (Germany) Business Overview
 Table 129. Qiagen (Germany) Gene Knockdown Product
 Table 130. Qiagen (Germany) Revenue in Gene Knockdown Business (2020-2025) & (US$ Million)
 Table 131. Qiagen (Germany) Recent Development
 Table 132. Research Programs/Design for This Report
 Table 133. Key Data Information from Secondary Sources
 Table 134. Key Data Information from Primary Sources
 Table 135. Authors List of This Report


List of Figures
 Figure 1. Gene Knockdown Picture
 Figure 2. Global Gene Knockdown Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Gene Knockdown Market Share by Type: 2024 VS 2031
 Figure 4. siRNA Features
 Figure 5. shRNA Features
 Figure 6. Other Features
 Figure 7. Global Gene Knockdown Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Gene Knockdown Market Share by Application: 2024 VS 2031
 Figure 9. Medical Case Studies
 Figure 10. Bioengineering Case Studies
 Figure 11. Other Case Studies
 Figure 12. Gene Knockdown Report Years Considered
 Figure 13. Global Gene Knockdown Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Gene Knockdown Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Gene Knockdown Market Share by Region: 2024 VS 2031
 Figure 16. Global Gene Knockdown Market Share by Players in 2024
 Figure 17. Global Top Gene Knockdown Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Knockdown as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Gene Knockdown Revenue in 2024
 Figure 19. North America Gene Knockdown Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Gene Knockdown Market Share by Country (2020-2031)
 Figure 21. United States Gene Knockdown Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Gene Knockdown Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Gene Knockdown Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Gene Knockdown Market Share by Country (2020-2031)
 Figure 25. Germany Gene Knockdown Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Gene Knockdown Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Gene Knockdown Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Gene Knockdown Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Gene Knockdown Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Gene Knockdown Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Gene Knockdown Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Gene Knockdown Market Share by Region (2020-2031)
 Figure 33. China Gene Knockdown Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Gene Knockdown Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Gene Knockdown Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Gene Knockdown Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Gene Knockdown Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Gene Knockdown Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Gene Knockdown Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Gene Knockdown Market Share by Country (2020-2031)
 Figure 41. Mexico Gene Knockdown Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Gene Knockdown Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Gene Knockdown Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Gene Knockdown Market Share by Country (2020-2031)
 Figure 45. Turkey Gene Knockdown Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Gene Knockdown Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Gene Knockdown Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Santa Cruz Biotechnology (US) Revenue Growth Rate in Gene Knockdown Business (2020-2025)
 Figure 49. OriGene (US) Revenue Growth Rate in Gene Knockdown Business (2020-2025)
 Figure 50. Sigma-Aldrich (US) Revenue Growth Rate in Gene Knockdown Business (2020-2025)
 Figure 51. Abnova (Taiwan) Revenue Growth Rate in Gene Knockdown Business (2020-2025)
 Figure 52. Agilent Technologies (US) Revenue Growth Rate in Gene Knockdown Business (2020-2025)
 Figure 53. Bio-Rad (US) Revenue Growth Rate in Gene Knockdown Business (2020-2025)
 Figure 54. Cell Signaling Technology (US) Revenue Growth Rate in Gene Knockdown Business (2020-2025)
 Figure 55. GeneCopoeia (US) Revenue Growth Rate in Gene Knockdown Business (2020-2025)
 Figure 56. siTOOLs Biotech (Germany) Revenue Growth Rate in Gene Knockdown Business (2020-2025)
 Figure 57. Novus Biologicals (US) Revenue Growth Rate in Gene Knockdown Business (2020-2025)
 Figure 58. EMD Millipore (US) Revenue Growth Rate in Gene Knockdown Business (2020-2025)
 Figure 59. BioVision (US) Revenue Growth Rate in Gene Knockdown Business (2020-2025)
 Figure 60. Creative Biomart (US) Revenue Growth Rate in Gene Knockdown Business (2020-2025)
 Figure 61. Selleck Chemicals (US) Revenue Growth Rate in Gene Knockdown Business (2020-2025)
 Figure 62. MyBioSource (US) Revenue Growth Rate in Gene Knockdown Business (2020-2025)
 Figure 63. Invitrogen (US) Revenue Growth Rate in Gene Knockdown Business (2020-2025)
 Figure 64. Qiagen (Germany) Revenue Growth Rate in Gene Knockdown Business (2020-2025)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Gene Gun Market Research Report 2024
Global Gene Chip Market Research Report 2025
Global Gene Edited Food Market Research Report 2024
Global Gene Editing Therapy Market Research Report 2024
Global Gene Service Market Research Report 2025
Gene Expression Chip Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gene Cloning Service Market Research Report 2025
Global PCR Gene Amplifier Market Research Report 2025
Global Gene Microarray Chip Market Research Report 2024
Global CRISPR Gene Editing Service Market Research Report 2025
Global Gene Editing Kit Market Research Report 2024
Global Gene Knockdown Service Market Research Report 2024
Global In Vitro Gene Therapy Market Research Report 2025
Global Reproductive Genetics Market Research Report 2024
Gene Deletion Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Targeted Gene Sequencers Market Research Report 2024
Global Gene Synthesis Software Market Research Report 2025
Global Gene Knockdown Stable Cell Line Service Market Research Report 2024
Global Gene Subcloning Service Market Research Report 2025
Global Gene Cloning Technology Services Market Research Report 2024

RELATED REPORTS

Global BYOD Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-11T6229
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Translation Management Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-36Z5964
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Archiving Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-11S6221
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Point of Sale Automation System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-11J6299
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions